checkAd

    Update on the merger approval process for the combination of Novozymes and Chr. Hansen  341  0 Kommentare The parties have submitted a remedy proposal to the European Commission.

    November 20, 2023


    Please see attachment.


    Contact information

    Investor Relations
    Anders Mohr Christensen
    +45 2515 2364
    dkamc@chr-hansen.com

    Press Relations
    Sanne Seyer-Hansen
    +45 6038 6207
    dksash@chr-hansen.com

    Lesen Sie auch

    Attachment



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors


    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Update on the merger approval process for the combination of Novozymes and Chr. Hansen The parties have submitted a remedy proposal to the European Commission. November 20, 2023 Please see attachment. Contact information Investor RelationsAnders Mohr Christensen+45 2515 2364dkamc@chr-hansen.com Press RelationsSanne Seyer-Hansen+45 6038 6207dksash@chr-hansen.com Attachment …